Drug Side Effects
Search
CONGENITAL PARVOVIRUS B19 INFECTION
CONGENITAL PARVOVIRUS B19 INFECTION
was reported 1 times
These drug classes are most commonly taken by patients reporting CONGENITAL PARVOVIRUS B19 INFECTION:
#
Drug
Count
0
Calcium [EPC]
1
1
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
1
2
Nonsteroidal Anti-inflammatory Drug [EPC]
1
3
Platelet Aggregation Inhibitor [EPC]
1